Enterprise Resource Strategic Transformation Of The Pharmaceutical Companies

Under the market competition environment of information age, strategic management has become the decisive factor of the enterprises sustainable development, and strategic transformation is a pioneering research in the field of strategic management. Although there have been many research achievements of strategic transformation, there is so little research about the role of enterprise resource in enterprise strategic transformation and how specific resource influencing strategy transformation, especially in China's specific conditions. Therefore, in China's specific conditions, it is very necessary to have a research on how the enterprise resource influencing the strategic transformation.Under the unique environment of transition Economy in china, this paper has a comprehensive analysis of previous studies, defines the concept of organizational resources, analyses the classification of organizational resources, and focuses on the analysis of the status of Chinese pharmaceutical industry, the driver and the path of implementing strategic transformation by pharmaceutical enterprise. Following the resource theory and the strategic inflection point theory, this paper builds a research framework of the possible influence exerting by the enterprise resource when the strategic of pharmaceutical companies shifts.In this paper, qualitative analysis and quantitative analysis methods: logically has qualitative analyses how the enterprise resource play a role on the strategic transformation of pharmaceutical enterprise. Also this paper uses the date of Chinese Pharmaceutical Industry from 2007 to 2009, and adopts the logistic regression analysis method.Through the empirical analysis, we conclude that, during the 90% confidence interval, financial assets, organizing ability, prior accounting-based performance and human capital have something to do with the possibility of strategic shift of some sexual relation. Financial assets of the strategic transformation of the pharmaceutical companies is positive, the regression coefficient is 0.647, The higher the financial assets, the easier the strategy transfer behavior implemented. Organizational capacity of the strategic restructuring of the pharmaceutical industry is negative, the regression coefficient is-1.529, the enterprise which has more organization ability will reduce the possibility of the implementation of the strategic shift. Historical performance of the strategic transformation of the pharmaceutical companies is negative, regression coefficient-0.064, Prior accounting-based performance will hinder the pharmaceutical enterprises implementing strategic transformation. Human capital on strategic transformation of the pharmaceutical companies is positive, the regression coefficient is 0.02, The richer the human capital, the higher the tendency, that the pharmaceutical enterprises implementing strategic transformation. Correlation between other variables and strategic transformation is not significant. These research results have a certain degree guiding value to of the strategic transition of pharmaceutical enterprise in China.